Athira Pharma Inc
ATHAAthira Pharma is a clinical stage American therapeutics company developing regenerative therapies for neurological diseases such as Alzheimer's disease and Parkinson's disease. The company's main product is in very early human studies for Alzheimer's disease as of 2019.The company was founded in 201 …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Athira Pharma Inc
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 1/5/2024 | Sell | Lenington, Rachel | Chief Operating Officer | $2.9 | $14,038 |
| 1/5/2024 | Sell | Worthington, Mark | General Counsel | $2.9 | $14,038 |
| 1/5/2024 | Sell | Litton, Mark James | Chief Executive Officer | $2.9 | $28,052 |
| 1/5/2024 | Sell | Church, Kevin | CHIEF SCIENTIFIC OFFICER | $2.9 | $7,019 |
| 1/5/2024 | Sell | Gengos, Andrew | CFO AND CHIEF BUSINESS OFFICER | $2.9 | $3,515 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)